Any feedback?
Please rate this page
(search_result.php)
(0/150)

BRENDA support

Refine search

Search Protein Variants

show results
Don't show organism specific information (fast!)
Search organism in taxonomic tree (slow, choose "exact" as search mode, e.g. "mammalia" for rat,human,monkey,...)
(Not possible to combine with the first option)
Refine your search

Search term:

Results 1 - 10 of 20 > >>
EC Number Protein Variants Commentary Reference
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.76F180A/F181A mutant is still able to display membrane PR3 after degranulation, with similar fluorescence intensity as wild-type 717959
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.76F180A/F181A/L228A/F229A contrary to wild-type, membrane anchorage is abrogated in mutant. Mutant is still able to cleave the synthetic substrate Boc-Ala-Pro-Val in cell lysates, but fails to cleave extracellular fibronectin, is not externalized after apoptosis and does not impair macrophage phagocytosis of apoptotic cells, does not promote myeloid cell proliferation and fails to cleave p21/waf1 717959
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.76F180A/L228A/F229A mutant is still able to display membrane PR3 after degranulation, with similar fluorescence intensity as wild-type 717959
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.76H4A site-directed mutagenesis 754130
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.76L228A mutant is still able to display membrane PR3 after degranulation, with similar fluorescence intensity as wild-type 717959
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.76L228A/F229A mutant is still able to display membrane PR3 after degranulation, with similar fluorescence intensity as wild-type 717959
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.76more catalytically inactive Ser195-substituted PR3 variant, eliminates quality check of the antigen preperation. Recombinant PR3 variants which only carry a single antigenic region on its surface may be used to neutralize or eliminate circulating anti-neutrophil cytoplasmic antibodies (ANCA) in patients without triggering immune complex-mediated type III reactions 686188
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.76N102Q glycosylation deficient recombinant PR3 mutant, hydrolytic activity like recombinant PR3-wild-type. N-terminal processing is delayed 687439
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.76N102Q/N147Q glycosylation deficient recombinant PR3 mutant, reduction in hydrolytic activity in relation to recombinant PR3-wild-type. Reduction in hydrolytic activity is more pronounced than the reduction induced by deglycosylation of purified neutrophil PR3. N-terminal processing is delayed 687439
Display the word mapDisplay the reaction diagram Show all sequences 3.4.21.76N147Q glycosylation deficient recombinant PR3 mutant, is processed like recombinant PR3-wild-type 687439
Results 1 - 10 of 20 > >>